BioCentury
ARTICLE | Clinical News

ATR-101: Phase I started

October 21, 2013 7:00 AM UTC

Atterocor began an open-label, U.S. Phase I trial to evaluate ascending doses of oral ATR-101 in about 21 patients. Atterocor also said ATR-101 received Orphan Drug designation in the U.S. and EU. ...